Table 4.
Predictors for diabetic painful neuropathy in primary and secondary healthcare
| Painful neuropathy | AOR | 95% CI | P‐value |
|---|---|---|---|
| Sex | |||
| Male | 1 | ||
| Female | 1.2 | 0.9–1.6 | 0.32 |
| Ethnic groups | |||
| Arabs | 1 | ||
| South Asians | 0.7 | 0.5–1.0 | 0.03 |
| Age | |||
| 20–50 years | 1 | ||
| 51–60 years | 1.5 | 1.1–2.0 | 0.02 |
| >60 years | 1.5 | 1.1–2.2 | 0.02 |
| Duration of diabetes | |||
| ≤10 years | 1 | ||
| 11–20 years | 2.2 | 1.6–3.0 | <0.0001 |
| >20 years | 4.4 | 2.7–7.1 | <0.0001 |
| Poor glycemic control | 1.2 | 0.9–1.6 | 0.2 |
| Hyperlipidemia | 1.1 | 0.8–1.5 | 0.58 |
| Hypertension | 1.3 | 0.9–1.8 | 0.13 |
| Obesity | 1.6 | 1.2–2.2 | 0.002 |
| Physical activity | 0.6 | 0.4–0.9 | 0.01 |
| Antidiabetic therapy | |||
| Metformin/plus other therapy | 1 | ||
| Insulin/plus | 1.7 | 1.3–2.4 | <0.0001 |
| Primary healthcare | 1 | ||
| Secondary healthcare | 2.4 | 1.6–3.5 | <0.0001 |
The multiple logistic regression model included all variables with P‐value of ≤0.05 at the bivariate level. Adjusted odds ratios (AOR), their corresponding 95% confidence intervals (CI) and P‐value are presented.